Eli Lilly (LLY) on Tuesday lowered the price of its weight-loss drug Zepbound for some patients paying out of pocket and int🎶roduced two new available vial doses.

A 2.5-milligram dose of injectable Zepbound will now cost $349 per month and a 5-mg dose of $499 per month, down from a respective $399 and $549 per month, a spokesperson told Investopedia.

The company also launched new 7.5-mg and 10-mg single-use vials, which cost $499 when refilled every 45 days through Eli Lilly's new "Zepbound Self Pay Journey Program." The vials "are priced at $599 and $699, respectively, if refilled outside of the 45-day window," Lilly said.

The offerings are available solely through LillyDirect Self Pay Pharmacy Solutions, which the company said "enables a transparent price by removing third-party supply chain entities and allowing patients to access savings directly outside of insurance."

Zepbound is approved by the 澳洲幸运5官方开奖结果体彩网:Food and Drug Administration (FDA) for both 澳洲幸运5官方开奖结果体彩网:weight loss and sleep apnea. It is injected once weekly, with recommended maintenance doses of 5 mg, 10 mg, or 15🔯 mg, the compan🐲y said.

Lilly's Q4 Zepbound Sales Had Missed Expectations

The price adjustments come after Eli Lilly recently reported 澳洲幸运5官方开奖结果体彩网:fourth-quarter sales of Zepbound and f𓂃ellow weight-loss drug Mounjaro that missed analysts' exp🍌ectations.

Shares of Eli Lilly were up more than 2% intraday Tuesday and have risen 17% over the past 12 months.